Lieuwke Kranenburg is an Assistant Professor at the Faculty of Veterinary Medicine , Utrecht University , specializing in Equine Internal Medicine . She provides patient care at the University Equine Clinic and teaches Master's courses in equine digestion , infectious diseases , and skin problems . Research Focus: Equine internal medicine, digestive diseases, infectious pathogens, metabolic disorders Professional Certifications: EBVS® European Veterinary Specialist in Equine Internal Medicine International Collaboration: Trained Chinese veterinarians at Heilan Equestrian Centre Publications highlight her work on equine gastric disease management, diagnostic imaging, infectious disease epidemiology, and metabolic research. She contributes to equine clinical research through peer-reviewed journals and conference abstracts. Professional Involvement: Former board member of the Equine Medicine Group and current GGP representative for FEEVA, maintaining professional networks and advancing equine veterinary practice.
Andrew T Arndt, MD is a Clinical Assistant Professor in the Department of Surgery specializing in Thoracic Surgery at Northwestern University's Feinberg School of Medicine. Board certified by the American Board of Thoracic Surgery, he maintains clinical practice at Northwestern Medicine Central DuPage Hospital and holds active memberships in the Society of Thoracic Surgeons (2023-present) and American Board of Thoracic Surgery (2022-present). His research concentrates on advancing thoracic surgical oncology through investigations into lung cancer resection outcomes, chest wall tumor management, minimally invasive techniques, and pneumothorax recurrence factors. Current work emphasizes evidence-based risk stratification and surgical innovation to improve patient outcomes in complex thoracic pathologies. Recent publications demonstrate consistent focus on surgical registry analysis (2021), consensus development for thoracoscopic training (2021), systematic reviews of rare chest wall malignancies (2023), and identification of lifestyle-related recurrence risks (2021). This trajectory highlights growing contributions to thoracic surgical guidelines and evidence-based practice standards. Dr. Arndt serves as a consultant for Intuitive Surgical, Inc. (2024 disclosures) while maintaining active clinical and academic roles. No formal advisees or research grants are listed in current profile materials. Within Northwestern's Department of Surgery, he contributes to the Thoracic Surgery division's clinical and research missions, particularly in advancing minimally invasive approaches and multidisciplinary management of complex thoracic conditions through collaborative registry studies and consensus initiatives.
Prof. Ajay Puri serves as Chief of Orthopaedic Oncology and Professor & Head of Surgical Oncology at Tata Memorial Centre. He holds leadership positions including President of the Indian Musculoskeletal Oncology Society, President Elect of the Asia Pacific Musculoskeletal Tumor Society, and past Chairman of the Indian Orthopaedic Association (Oncology). His research integrates clinical, biomedical, and basic science approaches to musculoskeletal tumors. Key contributions include developing low-cost indigenous megaprostheses widely adopted across Asia and Africa, pioneering biological reconstruction techniques after oncologic resection, and leading the International Sarcoma Kindred Study (ISKS) to investigate sarcoma genetics. His work bridges innovative surgical solutions with resource-limited healthcare settings. With over 100 publications and numerous book chapters, he shapes discourse in orthopaedic oncology through editorial roles at Bone & Joint-360, Sarcoma, and Frontiers in Orthopedic Surgery. As principal investigator for multiple studies, he drives translational research while mentoring through institutional frameworks at Tata Memorial Centre.
Prim. Clin. Assoc. Prof. PD Dr. Dietmar Dammerer, MSc PhD is the head of the Clinical Department of Orthopaedics and Traumatology at Krems University Hospital, affiliated with Karl Landsteiner Private University of Health Sciences. He has been in this role since February 2022, leading the merger of orthopedics and traumatology into a unified clinical department. A dual-trained specialist, he is recognized for his expertise in endoprosthetics and tumor orthopedics, and actively promotes interdisciplinary collaboration and team-based medicine. His educational background includes a PhD in Musculoskeletal Sciences (2015), an MSc in Advanced Orthopaedics and Traumatology (2017), and board certification in both orthopedics and traumatology (2017, 2018), culminating in habilitation in 2019. He has received prestigious Traveling Fellowships from the European Hip Society and European Musculo-Skeletal Oncology Society. Dietmar Dammerer’s research focuses on orthopedic oncology, joint reconstruction, biomechanics, and minimally invasive surgery. His work emphasizes the integration of clinical inquiry with research to improve patient outcomes. Recent publications analyze pelvic sarcoma reconstruction, spinal metastases, cartilage repair techniques, and health disparities in sarcoma care. His 15 most recent articles reflect a strong trend in musculoskeletal oncology, surgical biomechanics, and evidence-based orthopedic practice, with frequent use of systematic reviews, retrospective studies, and multicenter collaborations. Topics include implant performance, surgical safety, and global access to specialized care. Scientific awards include: Traveling Fellow Stipendium from the European Hip Society (2018) Traveling Fellow Stipendium from the European Musculo-Skeletal Oncology Society (2020) He is deeply committed to mentoring and team development, emphasizing that medical success is measured by the success of one’s colleagues. He leads a research-active department that hosts international observers, conducts training courses for physicians across Europe, the Middle East, and Africa, and maintains a high rate of peer-reviewed publication. The department collaborates closely with the Departments of Biomechanics and Anatomy and Developmental Biology, reflecting a multidisciplinary research approach.
Dr. Richard H. Wiggins serves as Professor of Radiology and Imaging Sciences at the University of Utah School of Medicine, where he also holds the position of Associate Dean of Continuing Medical Education. He maintains adjunct professorships in Otolaryngology, Head and Neck Surgery, and Biomedical Informatics. His educational background includes a BA in Biochemistry from the University of Texas at Austin and an MD from the University of Texas at Houston Health Sciences Center, followed by specialized training at the University of Florida and University of Utah. Dr. Wiggins's research spans neuroradiology, biomedical informatics, and medical education innovation. His work explores advanced imaging techniques for head and neck pathologies, PET-CT applications in oncology, and the development of novel educational platforms like the RadDiscord community. He maintains particular expertise in temporal bone imaging, paragangliomas, and thyroid nodule classification systems. Analysis of his recent publications shows strong emphasis on: (1) optimizing oncologic imaging protocols, especially PET-CT applications across cancer types; (2) advancing head and neck radiology through volumetric analysis and radiomics; and (3) transforming radiology education via gamification and digital communities. His scientific honors include: Distinguished Teaching Award (Otolaryngology, University of Utah) Honored Educator Award (Radiological Society of North America) Inaugural Fellow, Academy of Health Science Educators 25th Fellow of the Society of Imaging Informatics in Medicine Fellow of the American College of Radiology He leads the Utah Head and Neck Imaging Center of Excellence, which includes an educational YouTube channel (@UHNICE). While specific grants aren't detailed, his extensive lecture record (600+ presentations) and leadership roles in professional societies like SIIM (Program Chair 2014-2020), ASHNR (Past President), and WNRS (Past President) demonstrate significant academic influence.
Li Liu is the Sir Robert Ho Tung Professor in the Department of East Asian Languages and Cultures at Stanford University. She joined the Stanford faculty in 2010, following 14 years at La Trobe University in Melbourne, Australia, where she taught archaeology and was elected a Fellow of the Academy of Humanities in Australia. Her research focuses on early China's archaeology, encompassing the Neolithic and Bronze Ages, ritual practices, cultural interactions with the Old World, domestication processes, state formation, and urban development. She holds a B.A. in Archaeology from Northwestern University (Xi'an), an M.A. in Anthropology from Temple University (Philadelphia), and a Ph.D. in Anthropology from Harvard University (1994). Dr. Liu's educational background includes degrees from prestigious institutions across multiple countries, reflecting her global academic engagement. Her work bridges archaeological methods with interdisciplinary approaches to understand societal complexity and environmental adaptation in ancient China. Notably, her contributions to understanding cultural exchanges between China and neighboring regions have been influential in East Asian Studies. Her research interests emphasize material culture analysis, settlement patterns, and the socio-political dynamics underlying early state formations. This includes investigations into ritual landscapes, agricultural practices, and urbanization processes in ancient China. Her studies often involve collaborative projects that integrate archaeological data with historical and anthropological perspectives. Dr. Liu has been recognized for her scholarly contributions, including her Fellowship in the Australian Academy of Humanities. Though her primary role is in archaeology, her Google Scholar publications reflect interdisciplinary collaborations in medical research, audio engineering, and environmental science, suggesting diverse academic engagements. In advising, she mentors students in archaeological and anthropological studies, though specific advisee names are not listed here. Her grants and funding history, while not detailed in the text, would likely support her archaeological fieldwork and interdisciplinary projects. She has contributed to the Stanford Center for East Asian Studies and affiliated programs, fostering cross-cultural research initiatives.
Dr. Megan Anderson is Associate Professor of Orthopedic Surgery at Harvard Medical School and Director of the Orthopedic Oncology Program at Boston Children's Hospital. She completed her MD at University of Florida College of Medicine (1998), residency at Cleveland Clinic Foundation, and fellowship at Harvard-affiliated hospitals (2004). Her clinical practice focuses on bone tumors and sarcomas in pediatric and young adult populations. Research examines surgical outcomes in bone cancer treatment, particularly limb-salvage techniques and reconstruction complications. Recent publications analyze cost-effectiveness of preventive interventions in metastatic bone disease. Leads multidisciplinary collaborations through the Bone and Soft Tissue Tumors Program. Active in Musculoskeletal Tumor Society and Children's Oncology Group.
Elliot A. Asare, MD, MS, CMQ, FACS serves as Assistant Professor in the Section of Surgical Oncology within the Division of General Surgery at the University of Utah. He specializes in cutaneous malignancies and sarcomas of the retroperitoneum and soft tissues, practicing clinically at both Huntsman Cancer Institute and Intermountain Healthcare Center in Murray. His educational trajectory includes: Phi Beta Kappa graduate with B.S. in Biology and Chemistry (double major) from Randolph-Macon College M.D. from Howard University College of Medicine (Alpha Omega Alpha inductee) General Surgery residency at Medical College of Wisconsin Affiliated Hospitals M.S. in Health Services and Outcomes Research from Northwestern University Complex General Surgical Oncology fellowship at University of Texas MD Anderson Cancer Center Dr. Asare's research program centers on cancer staging methodology, data quality enhancement, prognostication frameworks, and outcomes research with emphasis on health disparities. His work integrates large-scale database analyses (SEER, National Cancer Data Base) to refine AJCC staging systems while addressing inequities in melanoma and sarcoma care across elderly, minority, and rural populations. Recent investigations explore sentinel lymph node biopsy efficacy in aging patients and viral infection impacts on melanoma mortality. His 2023-2025 publications reveal three dominant themes: (1) AJCC Version 9 implementation across multiple cancer types (anal, appendiceal, neuroendocrine), (2) persistent disparities in skin cancer outcomes linked to demographic and geographic factors, and (3) telehealth applications for expanding surgical oncology access. These studies consistently leverage national datasets to validate staging systems while identifying structural barriers to equitable care. Professional recognition includes: Phi Beta Kappa honor society membership Alpha Omega Alpha Medical Honor Society induction Fellowship in the American College of Surgeons (FACS) Dr. Asare actively contributes to surgical oncology education through The SCORE Portal as item writer for soft tissue neoplasm assessments and via publications on medical education frameworks. His institutional affiliations with Huntsman Cancer Institute and Intermountain Healthcare provide platforms for multidisciplinary sarcoma and melanoma management, where he integrates evidence-based staging protocols with patient-centered surgical approaches as evidenced by consistently high patient satisfaction scores (4.9/5 from 166 reviews).
Emmanuel M. Gabriel, M.D., Ph.D., serves as Associate Professor of Surgery and Consultant in the Department of Surgery at Mayo Clinic in Jacksonville, Florida. He directs clinical and research activities within the Mayo Clinic Comprehensive Cancer Center, specializing in surgical oncology for breast cancer, melanoma, sarcoma, and gastrointestinal malignancies requiring advanced regional therapies like HIPEC. His dual MD/PhD training uniquely positions him at the intersection of immunology research and complex cancer surgery. Dr. Gabriel's educational trajectory includes: MD/PhD in Immunology, Robert Wood Johnson Medical School (2009), thesis on regulatory T cells and cancer vaccines BA in Biology/Economics with Chemistry/Mathematics minors, Drew University (2002), Summa Cum Laude Residency and Administrative Chief Residency, UT Health San Antonio Department of Surgery Fellowship in Complex General Surgical Oncology, Roswell Park Cancer Institute His research program integrates two critical cancer domains: pioneering tumor imaging techniques to visualize immune-tumor interactions during surgery, and identifying systemic barriers in cancer care delivery through health disparities research. These efforts aim to personalize immunotherapy selection and develop equitable care pathways for underserved populations. Dr. Gabriel's scientific contributions are recognized through: Faculty Teacher of the Year awards from Mayo Clinic Department of Surgery (2022) Multiple Young Surgeon Research Awards from American College of Surgeons (2016) E. Douglas Holyoke Award as Outstanding Surgical Oncology Fellow (2016) Ongoing service as grant reviewer for national cancer organizations As an educator, he mentors surgical trainees through Mayo's integrated residency programs while leading translational research in the David F. and Margaret T. Grohne Cancer Immunology Program. His clinical practice directly informs research priorities, maintaining a continuous bench-to-bedside-to-community feedback loop. Dr. Gabriel's laboratory operates within Mayo Clinic's NCI-designated cancer center infrastructure, utilizing advanced imaging core facilities and population health resources to advance both immunotherapy development and health equity initiatives.
Gregory Skladzien, MD is an Assistant Professor at Rosalind Franklin University of Medicine and Science with dual appointments in the College of Health Professions (Physician Assistant Department) and Chicago Medical School (Department of Foundational Sciences and Humanities, Cell Biology and Anatomy), holding these positions since 2004 and 2003 respectively. Dr. Skladzien's educational background includes: BA summa cum laude from North Central College (1974) MD cum laude from Loyola University Stritch School of Medicine (1976) Residency in General Surgery at Loyola University Affiliated Hospitals (1976-1981) His research focuses on General Surgery with specialization in abdominal wall procedures, hernia management, and surgical oncology. His work bridges clinical practice with foundational sciences through dual departmental appointments in anatomy and cell biology, emphasizing case-based surgical education and age-related surgical challenges. His publication history from 1982-2006 features clinically significant case reports on rare surgical conditions including typhoid-related appendicitis and cutaneous sarcomas, alongside encyclopedia contributions on hernias in aging populations. These works demonstrate consistent expertise in complex general surgery with emphasis on public health implications. Professional recognition includes: Fellow, American College of Surgeons (1983-2000) No graduate student advising or research grants are documented in available records. Clinical practice history shows transition from active surgical service to emeritus status at Resurrection Medical Center since 2003.
Dr. Taran Rai is a Researcher at the University of Surrey, affiliated with the Centre for Vision, Speech and Signal Processing (CVSSP) and the School of Veterinary Medicine. His work focuses on computational pathology, deep learning for medical imaging, and applying AI to veterinary medicine. Rai holds a PhD and has contributed to advancements in necrosis and mitosis detection in canine tumors, leveraging CNNs and digital pathology. His research interests include AI-driven diagnostic tools, social media listening for health insights, and optimizing neural networks for medical applications. He has published extensively on topics like synthetic histopathology data evaluation, diffusion models, and adaptive thresholding methods in pathology. Rai's recent work explores the integration of large language models with medical imaging (e.g., the IPATH dataset) and addresses challenges in veterinary healthcare through social media data. His studies often bridge computational methods with real-world clinical needs, aiming to improve diagnostic accuracy and patient care.
Gregory T. MacLennan, MD is a Professor in the Department of Pathology and Department of Urology at the School of Medicine, Case Western Reserve University (CWRU), and a Physician at University Hospitals Cleveland Medical Center (UHCMC). He earned his MD from the University of Manitoba in 1971 and completed surgical and urology training in Canada and a urodynamics fellowship in the UK. After clinical practice in urology, he transitioned to anatomic pathology, completing further training at Mayo Clinic. Education: MD, University of Manitoba (1971) Fellowship in Urodynamics, St. Peter’s Hospitals, London (1977–1978) Training in Anatomic Pathology & Cytopathology, Manitoba Affiliated Teaching Hospitals (1989–1994) Fellowship in Surgical/Urologic Pathology, Mayo Clinic (1994–1995) Research Interests: Dr. MacLennan specializes in genitourinary pathology, focusing on diagnostic surgical and cytopathology. His work integrates clinical and basic science collaborations, addressing urogenital and reproductive system pathologies. Key areas include tumors like liposarcoma, renal pseudotumors, and urachal adenocarcinoma, emphasizing multidisciplinary approaches with urologists, oncologists, and radiologists. Key Roles: Director of Human Tissue Procurement Facility (17 years) Director of Surgical Pathology (8 years) Division Chief of Anatomic Pathology (7 years) Editorial Board Member, Journal of Urology (7 years) Awards: 2015: Inducted into CWRU Urology Department Hall of Fame Specialist Certification: Royal College of Physicians and Surgeons of Canada Board Certification: American Boards of Urology and Pathology Labs & Collaborations: Collaborates with clinical and basic science teams across UHCMC and CWRU, contributing to advancements in diagnostic and molecular pathology.
Luis Alberto Velasquez Zarate is an Assistant Professor at the Medical College of Georgia, where he holds appointments in the Department of Pathology with a subspecialty focus in Anatomic Pathology. He is actively involved in clinical research and diagnostic pathology, contributing to advancements in cancer classification and molecular diagnostics. Research Interests: His work spans anatomic pathology with emphasis on rare tumors, cancer epidemiology using population databases, and molecular techniques in cytology and sarcoma diagnostics. Key areas include endocrine, gynecologic, and soft tissue pathology, with a strong methodological foundation in SEER database analysis and immunohistochemical validation. The recent publications highlight a consistent trend in utilizing large-scale epidemiological data (SEER) to analyze incidence and survival in rare malignancies, combined with deep dives into molecular markers such as YWHAE and NKX2.2 for diagnostic precision in sarcomas and the application of FISH in pancreatobiliary lesions. This reflects a dual focus on population health and precision pathology. Service: Committee Member, Society of Pediatric Pathology (2021–Present) Education: MD in Medicine, Universidad San Martin De Porr (2009) Certified by GA Composite Medical Board (2018, 2022) Dr. Velasquez Zarate’s research contributes significantly to the understanding of rare cancers and diagnostic innovation in surgical pathology. While no formal advisees or awards are listed, his scholarly output indicates active engagement in translational pathology research. He plays a service role in a national pathology society, suggesting professional integration and contribution to the specialty.
Dr. Michelle Ghert is a Professor in the Department of Orthopaedics at the University of Maryland School of Medicine , with a distinguished career in orthopaedic oncology . She completed her residency at Duke University and fellowship at University of Toronto , and previously held academic appointments at McMaster University from 2005–2017 before joining Maryland in 2024. Education : B.A.S. from Stanford University (1992), MD from Vanderbilt University (1996) Leadership : Principal investigator in international trials like PARITY and SAFETY , shaping sarcoma care standards Her research focuses on musculoskeletal tumor management and complex limb reconstruction , with expertise in randomized controlled trials for surgical and oncology protocols. She has received prestigious awards including the 2023 Kappa Delta Ann Doner Vaughan Award and 2019 J. Édouard Samson Award , and holds active grants from NIH , DOD , and the Canadian Cancer Society .
Maggie L Chow is a Clinical Assistant Professor at the University of Southern California within the Department of Dermatology . Her clinical and academic work focuses on dermatologic conditions, including skin cancer, HIV-related dermatology, and complex drug reactions. Specialties: Dermatology, Cutaneous Oncology, Medical Education Location: Los Angeles County Hospital Email: chowmagg@usc.edu Research Interests Dr. Chow's research spans various dermatologic themes: Skin Cancer: Epidemiology and clinical presentations in diverse populations. Medical Education: Development of assessment tools for procedural skills. Infectious Diseases: Cutaneous manifestations in HIV patients. Drug Reactions: DRESS syndrome and toxicities. Publication Trends Her recent work emphasizes clinical education tools (e.g., OSATS for sclerotherapy), ethnic disparities in melanoma and nonmelanoma skin cancer, and management of rare conditions like livedoid vasculopathy and DRESS syndrome. Earlier collaborations include genetic studies in autism and neurodegenerative disease.
